FDA Approves First Treatment for COVID-19
The U.S. Food and Drug Administration has approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at least …
Read MorePlacebo-controlled study
Baudax Bio Announces Presentation of New Phase IIIb ANJESO® Data
MALVERN, PA — Baudax Bio, Inc. (NASDAQ: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, announced a virtual poster presentation highlighting new Phase IIIb ANJESO® (meloxicam) injection …
Read More